{"schema_version":"secwatch.filing_event.v1","accession":"0000915913-22-000134","form_type":"8-K","ticker":"ALB","cik":"0000915913","company_name":"ALBEMARLE CORP","filed_at":"2022-08-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:58.580481+00:00","generated_at":"2026-06-24T05:36:53.858305+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Albemarle Q2 sales $1.48B (+91% YoY); raises FY2022 guidance sharply","bullets":["Net income $406.8M ($3.46 GAAP EPS); adjusted diluted EPS $3.45, up 288% YoY.","Lithium segment sales $891.5M (+178%), adjusted EBITDA $495.2M (+353%) on higher pricing and volumes.","FY2022 guidance raised: net sales $7.1-7.5B, adjusted EBITDA $3.2-3.5B, adjusted EPS $19.25-22.25.","Kemerton I lithium plant in Australia achieved first product in July 2022.","Catalysts segment adjusted EBITDA down 53.7% due to cost pressures; strategic review ongoing."],"urls":{"canonical":"https://secwatch.observer/filing/0000915913-22-000134","json":"https://secwatch.observer/filing/0000915913-22-000134.json","markdown":"https://secwatch.observer/filing/0000915913-22-000134.md","text":"https://secwatch.observer/filing/0000915913-22-000134.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/915913/000091591322000134/0000915913-22-000134-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/915913/000091591322000134/alb-20220803.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T05:36:53.858305+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}